Evidence map›Paper›PMID 41211561›Full record

ArticleFood science and biotechnology2025

Whey-enhanced serum-free medium for bovine myoblast expansion.

Makoto Segawa, Yasutaka Nishiyama, Eri Kitagawa, Takanori Hasegawa

Abstract read
In one paragraph

Article in Food science and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Makoto SegawaR&D Center, NH Foods Ltd., 3-3 Midorigahara, Ibaraki, 300-2646 Japan.
Yasutaka NishiyamaR&D Center, NH Foods Ltd., 3-3 Midorigahara, Ibaraki, 300-2646 Japan.
Eri KitagawaR&D Center, NH Foods Ltd., 3-3 Midorigahara, Ibaraki, 300-2646 Japan.
Takanori HasegawaR&D Center, NH Foods Ltd., 3-3 Midorigahara, Ibaraki, 300-2646 Japan.ORCID 0009-0002-7483-166X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cell-based foods are anticipated to be a sustainable alternative to animal protein sources. The primary challenge is developing a food-grade serum-free medium (SFM) that is affordable, safe, acceptable to consumers, and available in large quantities. This study was conducted to develop such a medium using food ingredients dissolved in water that support the expansion of bovine myoblasts and maintain their differentiation capability. Through screening of various food ingredients, whey was identified as the most effective component. Whey improved myoblast proliferation in SFM to levels than those in a serum-containing medium. The differentiation capability of myoblasts cultured in whey-containing SFM was similar to that in serum-containing medium. Remarkably, whey could support myoblast proliferation even after heat treatment, allowing for the sterilization of whey-containing media by heat treatment, a common process in food processing. Hence, whey could be an ideal ingredient for affordable food-grade serum replacement in cell-based food production.

Indexed as

Cell-based foodsFood-grade mediumMyoblastsSerum-free mediumWhey

Identifiers

PMID41211561
PMCPMC12589749

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.